Building on a rich tradition of hosting the event in Zürich, the 2024 edition of the conference is headed to a new location in Muttenz, taking advantage of networking and technology strengths that Basel, Switzerland’s pharmaceutical capital, has to offer. The scientific excellence and diverse program that attendees appreciate will remain unchanged.
Prof. Molly Stevens, FRS FREng (UK)
University of Oxford
Prof. Dr. David W. Grainger (USA)
The University of Utah
Prof. Dr. Suzie H. Pun (USA)
University of Washington
Prof. Dr. Massimo Mastrangeli (NL)
Delft University of Technology
Prof. Dr. Chantal Pichon (FR)
CNRS University of Orleans
Prof. Dr. Khalid Salaita (USA)
Emory University
Prof. Dr. Carole Bourquin (CH)
University of Geneva
Dr. Gregoire Altan-Bonnet (USA)
National Cancer Institute NIH
Prof. Dr. Joachim Spatz (DE)
Max Planck Institute for Medical Research, Heidelberg University
